Linda O′Flaherty

2.0k total citations
9 papers, 668 citations indexed

About

Linda O′Flaherty is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Linda O′Flaherty has authored 9 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Linda O′Flaherty's work include Cancer, Hypoxia, and Metabolism (3 papers), Renal cell carcinoma treatment (2 papers) and Mitochondrial Function and Pathology (2 papers). Linda O′Flaherty is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Renal cell carcinoma treatment (2 papers) and Mitochondrial Function and Pathology (2 papers). Linda O′Flaherty collaborates with scholars based in United Kingdom, Germany and United States. Linda O′Flaherty's co-authors include Klaus Pantel, Sabine Riethdorf, Claudia Hille, Julie Adam, Patrick J. Pollard, Peter J. Ratcliffe, Konstantinos Giaslakiotis, Johannes Schödel, Christoph Loenarz and Ester M. Hammond and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Advanced Drug Delivery Reviews.

In The Last Decade

Linda O′Flaherty

9 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda O′Flaherty United Kingdom 9 422 295 196 102 76 9 668
Ming Yu China 15 279 0.7× 193 0.7× 192 1.0× 73 0.7× 43 0.6× 54 644
Chang‐Ying Guo China 10 527 1.2× 396 1.3× 155 0.8× 79 0.8× 41 0.5× 23 769
Astrid Katzer Germany 20 552 1.3× 343 1.2× 134 0.7× 110 1.1× 64 0.8× 28 891
Michael M. Lizardo United States 14 349 0.8× 222 0.8× 247 1.3× 196 1.9× 51 0.7× 24 746
Renbing Jia China 9 682 1.6× 389 1.3× 154 0.8× 92 0.9× 20 0.3× 20 938
Linxiang Lan United Kingdom 14 685 1.6× 330 1.1× 272 1.4× 71 0.7× 33 0.4× 17 965
Emmanuel Chautard France 18 515 1.2× 204 0.7× 274 1.4× 171 1.7× 46 0.6× 39 900
Robert D. Leone United States 5 466 1.1× 394 1.3× 406 2.1× 116 1.1× 129 1.7× 8 1.2k
Youbo Zhao China 13 454 1.1× 344 1.2× 90 0.5× 268 2.6× 183 2.4× 24 772

Countries citing papers authored by Linda O′Flaherty

Since Specialization
Citations

This map shows the geographic impact of Linda O′Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda O′Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda O′Flaherty more than expected).

Fields of papers citing papers by Linda O′Flaherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda O′Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda O′Flaherty. The network helps show where Linda O′Flaherty may publish in the future.

Co-authorship network of co-authors of Linda O′Flaherty

This figure shows the co-authorship network connecting the top 25 collaborators of Linda O′Flaherty. A scholar is included among the top collaborators of Linda O′Flaherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda O′Flaherty. Linda O′Flaherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
O′Flaherty, Linda, Steven D. Shnyder, Patricia A. Cooper, et al.. (2019). Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer. PLoS ONE. 14(4). e0214610–e0214610. 20 indexed citations
2.
Riethdorf, Sabine, Linda O′Flaherty, Claudia Hille, & Klaus Pantel. (2018). Clinical applications of the CellSearch platform in cancer patients. Advanced Drug Delivery Reviews. 125. 102–121. 205 indexed citations
3.
O′Flaherty, Linda, Harriet Wikman, & Klaus Pantel. (2017). Biology and clinical significance of circulating tumor cell subpopulations in lung cancer. Translational Lung Cancer Research. 6(4). 431–443. 28 indexed citations
4.
Vincent, Emma E., Douglas J.E. Elder, Linda O′Flaherty, et al.. (2014). Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation. PLoS ONE. 9(12). e114725–e114725. 26 indexed citations
5.
Ternette, Nicola, Ming Yang, Mitsuhiro Kitagawa, et al.. (2013). Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency. Cell Reports. 3(3). 689–700. 124 indexed citations
6.
Bardella, Chiara, Martina Olivero, Annalisa Lorenzato, et al.. (2012). Cells Lacking the Fumarase Tumor Suppressor Are Protected from Apoptosis through a Hypoxia-Inducible Factor-Independent, AMPK-Dependent Mechanism. Molecular and Cellular Biology. 32(15). 3081–3094. 29 indexed citations
7.
Thalhammer, Armin, Zuzana Bencokova, Rachel L. Poole, et al.. (2011). Human AlkB Homologue 5 Is a Nuclear 2-Oxoglutarate Dependent Oxygenase and a Direct Target of Hypoxia-Inducible Factor 1α (HIF-1α). PLoS ONE. 6(1). e16210–e16210. 126 indexed citations
8.
Zhdanov, Alexander V., Cédric Favre, Linda O′Flaherty, et al.. (2011). Comparative bioenergetic assessment of transformed cells using a cell energy budget platform. Integrative Biology. 3(11). 1135–1135. 29 indexed citations
9.
O′Flaherty, Linda, Julie Adam, Lisa C. Heather, et al.. (2010). Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism. Human Molecular Genetics. 19(19). 3844–3851. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Yu Breakdown of academic impact, for papers by Chang‐Ying Guo Breakdown of academic impact, for papers by Astrid Katzer Breakdown of academic impact, for papers by Michael M. Lizardo Breakdown of academic impact, for papers by Renbing Jia Breakdown of academic impact, for papers by Linxiang Lan Breakdown of academic impact, for papers by Emmanuel Chautard Breakdown of academic impact, for papers by Robert D. Leone Breakdown of academic impact, for papers by Youbo Zhao
Rankless by CCL
2026